PrognosisUS Inks Vaccine Deal With Moderna as Bird Flu Threat LoomsModerna gets $176 million to help develop an mRNA pandemic flu shot.
PrognosisModerna’s First Vaccine Was a Big Hit. Its Second Is a Let DownThe biotech’s first product for something other than Covid doesn’t clearly perform any better than other shots on the market.